On September 19th, Temasek Holdings and several domestic and foreign investment institutions visited the National Healthcare Security Administration to discuss and exchange views on how healthcare insurance supports the high-quality development of China Meheco. The National Healthcare Security Administration stated that in the next step, it will continue to implement relevant policy measures, make good use of healthcare insurance funds, policies, data, and other resources, and increase openness to support the development of pharmaceutical institutions, the advancement of medical technology, the innovation and improvement of drugs, and the transformation and upgrading of the industry. It welcomes domestic and foreign investment institutions to pay attention to the Chinese pharmaceutical industry, invest in the Chinese pharmaceutical industry, and focus on health and invest in health. Some of the investment institutions participating in the seminar include: AXA Investment Managers, Temasek Holdings, Rothschild & Co Asset Management, Value Partners, Sequoia PIPE, Sequoia Healthcare, Jianjun Capital, Royal Bank of Canada Global Asset Management, Hermes Fund Managers, Causeway Bay Asset Management, CITIC Lyon Securities, and CITIC Securities
